<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000641163"><TermName>Apo-2L</TermName><TermPronunciation>(AY-poh …)</TermPronunciation><TermDefinition><DefinitionText>A cell protein that can attach to certain molecules in some cancer cells and may kill the cells. Apo-2L is being studied in the treatment of cancer. Also called TNF-related apoptosis-inducing ligand, TRAIL,  and tumor necrosis factor-related apoptosis-inducing ligand.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000722562" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Apo-2L&quot;" language="en" id="_3"/><MediaLink ref="CDR0000722561" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Apo-2L&quot;" language="es" id="_4"/><SpanishTermName>Apo-2L</SpanishTermName><SpanishTermDefinition><DefinitionText>Proteína celular que se puede unir a ciertas moléculas de algunas células cancerosas y puede destruir las células. Apo-2L está en estudio para el tratamiento de cáncer. También se llama ligando inductor de apoptosis relacionada con el factor de necrosis tumoral, ligando inductor de apoptosis relacionada con el FNT,  y TRAIL.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2009-05-08</DateFirstPublished></GlossaryTerm>
